Neuropsychopharmacology
- Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis1 year ago
- Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression1 year ago
- Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia1 year ago
- Prediction of alcohol intake patterns with olfactory and gustatory brain connectivity networks1 year ago
- REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression1 year ago
- Validation of L-type calcium channel blocker amlodipine as a novel ADHD treatment through cross-species analysis, drug-target Mendelian randomization, and clinical evidence from medical records1 year ago
- Frontostriatal regulation of brain circuits contributes to flexible decision making1 year ago
Journal of Psychopharmacology
- Clinical quandaries in psychotic disorders: the road is long, with many a winding turn3 years ago
- Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats3 years ago
- Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)3 years ago
- Alterations of auditory sensory gating in mice with noise-induced tinnitus treated with nicotine and cannabis extract3 years ago
- Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies3 years ago
- Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial3 years ago
- Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis3 years ago
European Neuropsychopharmacology
- A posterior-alpha ageing network is differentially associated with antidepressant effects of venlafaxine and rTMS3 years ago
- The significance of an integrated multi-omics approach in psychiatric disorders: A pharmacological perspective3 years ago
- Substance P, NPY, CCK and their receptors in five brain regions in major depressive disorder with transcriptomic analysis of locus coeruleus neurons3 years ago
- Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study3 years ago
- Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia3 years ago
- Infection-associated chronic disability: A transdiagnostic and translational opportunity for neuroscience3 years ago
- Do epidemiologists choose the right tools to explore the impact of mental disorders over time?3 years ago